1189481-51-3
1189481-51-3
Chemical Structure
Elacridar-d4(Major)
- CAS No.: 1189481-51-3
- Formula:C34H29D4N3O5
- Molecular Weight:567.67
InChIKey: OSFCMRGOZNQUSW-RCYYZLFTSA-N
SMILES: O=C(NC1=CC=C(C([2H])(C([2H])(N2CCC(C=C(C(OC)=C3)OC)=C3C2)[2H])[2H])C=C1)C4=CC=CC5=C4NC6=C(C5=O)C=CC=C6OC
Biological Activity: Elacridar-d4(Major) is the deuterium labeled Elacridar (HY-50879). Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Elacridar-d4(Major) | Elacridar-d4(Major) is the deuterium labeled Elacridar (HY-50879). Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Elacridar (Standard) | 97.50% | Elacridar (Standard) is the analytical standard of Elacridar. This product is intended for research and analytical applications. Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Elacridar | 99.66% | Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
